Rising adoption of wearable drug delivery, continuous glucose monitoring, and home-based treatment drives demand for skin-friendly adhesives designed for extended wear
Rockville, Maryland — September 24, 2026 — Demand for wearable infusion adhesives is projected to increase significantly, with the market expanding from USD 0.4 billion in 2026 to USD 1.4 billion by 2036, advancing at a 13.3% CAGR during the forecast period. Growth is being supported by wider adoption of wearable drug-delivery devices, continuous glucose monitoring systems, and home-based treatment models requiring reliable skin attachment over extended wear periods.
Wearable infusion adhesives play an important role in maintaining secure contact between medical devices and the skin. As treatment and monitoring move beyond traditional clinical environments, adhesive performance is becoming increasingly important for patients using devices continuously at home, during daily activities, or over multiple days.
Get detailed market forecasts, competitive benchmarking, and pricing trends:
Acrylic Adhesives Lead the Market
Acrylic adhesives are projected to account for 37.0% of the market in 2026, making them the leading material segment. Their established adhesion performance across varied conditions makes them suitable for wearable medical devices requiring secure attachment during extended periods.
For device manufacturers, adhesive selection involves balancing holding strength with patient comfort and skin compatibility. Wearable applications can expose adhesive materials to movement, moisture, temperature variation, and repeated daily activity, increasing the need for materials that maintain attachment without creating unnecessary skin trauma.
The development of breathable and low-trauma formulations is therefore becoming an important focus as wearable healthcare devices gain wider acceptance.
CGM Devices Anchor Application Demand
Continuous glucose monitoring (CGM) devices are projected to account for 33.0% of the market in 2026. The expanding use of CGM technology is creating sustained demand for adhesives capable of maintaining consistent skin contact throughout the monitoring period.
CGM devices are typically worn for extended periods, making adhesion reliability an important consideration for patients and device manufacturers. Adhesives must maintain sufficient attachment while supporting comfort during everyday activities.
Beyond glucose monitoring, wearable infusion adhesives are finding applications across drug delivery and other connected healthcare devices. The growing integration of digital health technologies with wearable medical systems is creating additional opportunities for adhesive suppliers.
United States Leads Country-Level Growth
The United States is projected to expand at a CAGR of 13.8% through 2036, making it one of the fastest-growing markets covered in the study. Broader adoption of wearable drug-delivery systems and continuous glucose monitoring devices is supporting demand for advanced adhesive technologies.
Manufacturers are increasingly focused on materials that can provide stability and comfort throughout prolonged wear. The expanding use of connected healthcare technologies in both clinical and home settings is also creating opportunities for specialized adhesive solutions.
Germany is expected to register a 13.5% CAGR through 2036. Growth is being supported by continued development of advanced wearable medical devices and increasing demand for skin-friendly formulations.
Germany’s established healthcare and medical technology ecosystem is contributing to the adoption of wearable solutions, particularly as digital-health initiatives encourage greater use of connected devices for monitoring and treatment.
In Japan, the market is forecast to grow at a 13.2% CAGR during the forecast period. An aging population is increasing demand for home-healthcare technologies, creating opportunities for wearable infusion and monitoring devices that require dependable skin adhesion.
As more healthcare activities shift toward home settings, adhesive performance becomes increasingly relevant to device usability and patient experience.
Competitive Landscape
Key participants in the wearable infusion adhesives market include Solventum / 3M Medical Materials, Lohmann, Nitto Denko Corporation, and Henkel Adhesive Technologies.
These companies are focusing on the development of breathable, skin-compatible, and low-trauma adhesive materials designed for extended wearable applications. Partnerships with medical device manufacturers are also becoming important as adhesive suppliers work to develop materials suited to specific device architectures and use conditions.
Competition is increasingly centered on balancing adhesion strength with patient comfort. Suppliers must also accommodate requirements associated with continuous wear, moisture exposure, movement, and skin sensitivity.
As connected drug-delivery and remote-monitoring platforms expand, adhesive manufacturers have opportunities to develop specialized solutions that support the next generation of wearable healthcare technologies.
Unlock Actionable Insights from the Complete Report:
Market Outlook
The wearable infusion adhesives market is projected to grow from USD 0.4 billion in 2026 to USD 1.4 billion by 2036, reflecting a 13.3% CAGR.
The United States, Germany, and Japan are projected to record CAGRs of 13.8%, 13.5%, and 13.2%, respectively. Acrylic adhesives remain the leading material segment with a 37.0% share, while CGM devices account for 33.0% of the market.
The convergence of wearable drug delivery, continuous monitoring, digital health, and home-based healthcare is creating sustained demand for adhesives that can provide dependable attachment while supporting patient comfort.
For detailed segment forecasts, regional insights, competitive benchmarking, and pricing trends, explore the complete Fact.MR report on the Wearable Infusion Adhesives Market.
Explore More Related Studies Published by Fact.MR Research
Uveal Melanoma Treatment Market
About Fact.MR
Fact.MR is a global market research and consulting firm trusted by Fortune 500 companies and emerging businesses for reliable market intelligence and strategic insights. With a presence across the U.S., UK, India, and Dubai, the company delivers data-driven research and tailored consulting solutions across more than 30 industries and 1,000 markets. Backed by deep research expertise and advanced analytics, Fact.MR helps organizations evaluate market opportunities, understand competitive environments, reduce risks, and make informed decisions for sustainable growth.
Contact Us
11140 Rockville Pike, Suite 400
Rockville, MD 20852, United States
Tel: +1 (628) 251-1583
[email protected]
